Focus: Corvia Medical is a cardiovascular device company focused on developing the Interatrial Shunt Device (IASD) system to treat heart failure. The company operates as a pre-revenue medical device biotech based in Tewksbury, MA since 2010.
Profile data last refreshed 42m ago · AI intelligence enriched 2w ago
Corvia represents a speculative early-stage medical device play suitable for candidates seeking device-focused experience but with limited hiring momentum and unclear commercialization timeline.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Corvia Medical
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Corvia Medical's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Based on last 4 crawl cycles
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/mo